WO2013073431A1 - Beauty treatment method, skin care composition, bacterial cell, and dried bacterial cell - Google Patents

Beauty treatment method, skin care composition, bacterial cell, and dried bacterial cell Download PDF

Info

Publication number
WO2013073431A1
WO2013073431A1 PCT/JP2012/078835 JP2012078835W WO2013073431A1 WO 2013073431 A1 WO2013073431 A1 WO 2013073431A1 JP 2012078835 W JP2012078835 W JP 2012078835W WO 2013073431 A1 WO2013073431 A1 WO 2013073431A1
Authority
WO
WIPO (PCT)
Prior art keywords
bacteria
skin
useful
bacterium
care composition
Prior art date
Application number
PCT/JP2012/078835
Other languages
French (fr)
Japanese (ja)
Inventor
英俊 本多
格 出来尾
Original Assignee
株式会社バイオジェノミクス
学校法人九州文化学園
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社バイオジェノミクス, 学校法人九州文化学園 filed Critical 株式会社バイオジェノミクス
Priority to CN201280056675.7A priority Critical patent/CN103945829B/en
Priority to JP2013541091A priority patent/JP5584833B2/en
Publication of WO2013073431A1 publication Critical patent/WO2013073431A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/06Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A61Q5/065Preparations for temporary colouring the hair, e.g. direct dyes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/10Preparations for permanently dyeing the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/12Preparations containing hair conditioners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor

Definitions

  • the present invention relates to a cosmetic method, a skin care composition that can be applied to all persons and has almost no side effects regardless of individual differences in skin environment, and a microbial cell and a dry microbial cell suitably used for the production thereof.
  • Staphylococcus aureus a useful bacteria that kills the growth of Staphylococcus aureus.
  • Staphylococcus aureus a useful bacteria that is useful for maintaining a healthy skin condition. Maintaining the condition is useful for improving the condition of the skin or skin surface.
  • Staphylococcus epidermidis contributes significantly to maintaining the skin's moisturizing function and barrier function by producing glycerin, and also produces organic acids and keeps the skin surface weakly acidic. Therefore, it plays a major role in suppressing the growth of harmful bacteria (see Non-Patent Document 1, for example).
  • Staphylococcus epidermidis produces an antimicrobial peptide that inhibits the growth of Staphylococcus aureus, which is a harmful bacterium.
  • Patent Document 1 discloses that the balance of skin resident bacteria that works effectively only on the grown Acne bacteria (genus Propionibacterium) among the skin resident bacteria and does not act on aerobic bacteria is healthy.
  • a skin normal bacteria normalizing agent what has an auren extract as an active ingredient is disclosed.
  • Patent Document 2 discloses a skin resident flora-improving agent containing a water-soluble saccharide in which a plurality of sugars are ⁇ -bonded.
  • Patent Document 3 discloses an ecosystem balance regulator for skin resident bacteria containing hinokitiol glycoside as an active ingredient for bacteriostasis and sterilizing Staphylococcus aureus and causing Staphylococcus epidermidis to grow.
  • Patent Document 4 discloses one kind selected from a plant extract of the genus Kidney chicken and the genus Taconoki as an active ingredient having no bactericidal action against Staphylococcus epidermidis and having a bactericidal or growth-inhibiting action against Staphylococcus aureus. Or the ecosystem balance regulator of skin resident bacteria containing 2 or more types and bittern is disclosed.
  • Patent Documents 1 to 4 in which the skin resident flora is sounded by administering an exogenous compound, the drug resistance in harmful bacteria is acquired, the skin environment of each individual is different, etc. If the bacterial species constituting the skin resident flora are mutated and the drug susceptibility changes, there is a possibility that the soundening effect cannot be exhibited. It is extremely difficult to select an optimal drug according to such changes from a large number of candidate compounds in a custom-made manner.
  • the present invention has been made in view of the above problems, can easily cope with individual differences in the skin environment, has little adverse effects such as side effects, and healthy growth of the normal skin flora by selectively growing useful bacteria. It is an object of the present invention to provide a novel and safe cosmetic method, a skin care composition, and a dry cell body suitably used for the production thereof.
  • the present invention provides a cosmetic method described in [1] to [7] below, a skin care composition described in [8] to [12], a fungus body described in [13] to [17], and a dried [18].
  • the solution of the above-described problem is achieved by providing the bacterial cells.
  • a step of collecting bacteria that inhabit the human skin surface, and one or more useful bacteria that grow on the human skin surface and improve skin health among the bacteria are selectively grown.
  • a step of administering to the human skin a composition comprising one or more selected from the group consisting of cells of the proliferated useful bacteria, bacterial cell components, and substances produced by the useful bacteria .
  • the step of selectively growing the one or more kinds of useful bacteria comprises: A pre-culturing step of culturing the collected bacteria on a medium; A selection step of selecting the useful bacteria from the cultured bacteria; The cosmetic method according to any one of [1] to [3], further comprising a culture step of culturing the selected useful bacteria.
  • [15] The bacterial cell according to the above [13] or [14], wherein the bacterium lives on the skin surface of a healthy human state.
  • [16] The microbial cell according to any one of [13] to [15], wherein the useful bacterium is coagulase-negative staphylococci.
  • [17] The microbial cell according to [16] above, wherein the useful bacterium is Staphylococcus epidermidis.
  • Bacteria collected from human skin are particularly prone to growth in human-specific skin environments. Therefore, a composition containing one or a plurality of useful bacteria selectively grown from bacteria collected from the surface of human skin, or a cell component or product of useful bacteria that promotes the growth is applied to the human skin surface.
  • useful bacteria become dominant on the skin surface, so that the growth of harmful bacteria can be effectively suppressed, and thus the balance of the normal flora of the skin can be appropriately maintained.
  • the health condition of the skin can be reliably maintained or improved. Therefore, the cosmetic method and the skin care composition provided by the present invention are useful for keeping the skin condition healthy. Further, the cosmetic method and the skin care composition of the present invention have the advantages that they are safe and have few adverse effects such as side effects because no drug is used.
  • bacteria collected from the skin of an individual are adapted to individual differences in the skin environment and are particularly prone to proliferate in the skin environment unique to that individual. For this reason, when bacteria that have been selectively grown from bacteria collected from the skin surface of the individual are administered (returned) to the skin surface of the individual, the useful bacteria are exposed to the skin surface regardless of individual differences in the skin environment. By being dominant, it is possible to more effectively suppress the growth of harmful bacteria, and thus to keep the balance of the normal skin flora more appropriately.
  • a cosmetic method according to an embodiment of the present invention includes a skin resident bacteria (bacteria of bacteria) that inhabit the surface of an individual (human individual).
  • An example a step of selectively growing one or more kinds of useful bacteria that grow on the skin surface of individuals and improve the health of the skin among the skin resident bacteria, Administering (returning) a skin care composition containing one or more selected from the group consisting of bacterial cells, bacterial cell components and useful bacterial product to the skin of an individual.
  • a composition for skin care used in a cosmetic method comprises one or a plurality of types of useful bacteria isolated from bacteria collected from the surface of an individual's skin and selectively proliferated, components of the cells, and products of useful bacteria Including one or more selected from the group and collecting bacteria living on the surface of the individual's skin, and selectively growing only one or more useful bacteria from the collected bacteria; It is manufactured by the method containing.
  • each process regarding manufacture of the composition for skin care is demonstrated more concretely.
  • Bacterial collection Bacteria such as dozens of skin resident bacteria are present on the surface of the skin, but as a bacterium used in the production of a skin care composition, the skin condition is healthy. Any one of these may be used alone, or any two or more of them may be used in appropriate combination as long as they are useful for maintenance.
  • bacteria suitably used in the production of a skin care composition include human skin resident bacteria, and specific examples thereof include Staphylococcus epidermidis.
  • Various bacteria such as skin resident bacteria are present on the skin surface throughout the body, but are particularly abundant on the surface such as the face and armpits. Therefore, it is preferable to collect from these sites.
  • a skin care composition when used as a cosmetic, it is preferable to collect bacteria such as skin resident bacteria from the skin surface of the face. Since it is considered that the balance of skin resident bacteria is appropriately maintained on the healthy skin surface, it is preferable to collect the skin resident bacteria from the healthy (healthy) skin surface.
  • Bacteria can be collected using any method capable of collecting bacteria from the skin surface and isolating any strain.
  • a method of collecting by wiping the skin surface with any instrument such as a cotton swab, gauze, non-woven fabric, paper, sponge etc.
  • a method of transferring bacteria from the skin surface to the surface of the culture medium by pressing onto the surface of the medium a method of bringing a liquid such as water or physiological saline into contact with the skin surface, suspending the bacteria present on the skin surface in the liquid, and collecting it together with the liquid Etc. Since the bacterial species contained in the collected bacteria and the ratio of the numbers also serve as an index for diagnosing the health condition of the skin, it is preferable to collect the bacteria from a certain area on the skin.
  • bacteria When collecting bacteria by wiping the skin surface with a sterile cotton swab, in order to keep the area wiped with a sterile cotton swab constant, it is made of a synthetic resin, glass, etc., open at both ends, cylindrical, elliptical cylinder, or prismatic Bacteria may be collected by lightly adhering the collection tool to the skin and wiping all over the opening. By such a method, bacteria can always be collected from the skin surface within a predetermined area range.
  • bacteria when bacteria are collected using a method in which a sterilized agar medium is pressed against the skin surface, the bacteria are always removed from the skin surface within a certain area by using a medium having a predetermined area (radius). Can be collected.
  • the medium that can be used for collecting bacteria is not particularly limited, but specific examples of the medium used for collecting skin resident bacteria include standard agar medium, trypticase soy agar medium for normal living bacteria, egg yolk man Examples include selective separation media for staphylococci such as knit saline and salted egg agar.
  • recovery of bacteria is made to contact the skin surface, it is preferable to use the culture medium of the composition which does not contain the substance which may act as an allergen.
  • the bacteria collected from the skin surface as described above include both useful bacteria and harmful bacteria. Of these, only one or more desired useful bacteria are selectively grown.
  • selective growth methods there are a method in which only desired useful bacteria are isolated and cultured, and a method in which culture is performed under conditions in which only desired useful bacteria are grown, and either method may be used.
  • the step of selectively growing useful bacteria may include the following steps (i) to (iii). (I) Preliminary culture process for culturing collected bacteria on medium (ii) Selection process for identifying cultured bacteria and selecting useful bacteria (iii) Culture process for culturing selected useful bacteria
  • the pre-culture process may be performed as it is on the surface of the collected medium, but it is re-collected from the medium surface using a sterile cotton swab etc.
  • pre-culture may be performed using the same procedure as described above.
  • the culture medium include a medium for general bacteria such as trypticase soy agar medium (TS medium), a selective separation medium for the aforementioned staphylococci, and the like.
  • a bacterial species is identified and a useful microbe is selected.
  • a selection process can be performed using arbitrary well-known methods, it is performed in the following procedures, for example. First, the medium is visually observed, the number of colonies formed on the medium is counted, and, if possible, preliminary classification by appearance is performed. Then, bacterial species are identified for individual colonies or some representative of them. For example, in the case of Staphylococcus epidermidis, identification is performed by combining microscopic observation, Gram staining, and coagulase activity.
  • Staphylococcus epidermidis is coagulase negative (CNS) unlike pathogenic bacteria such as Staphylococcus aureus. Therefore, measurement of coagulase activity is important for discrimination from Staphylococcus aureus.
  • the useful bacteria selected (separated) from bacteria such as skin resident bacteria are cultured as described above. Culturing can be performed using any known method.
  • the useful bacteria obtained in this way are considered to be suitable for the environment of the skin surface of the individual from whom the skin resident bacteria were collected. Therefore, they are contained in the skin care composition and administered (returned) to the skin surface of the individual. ), It proliferates predominantly on the skin surface, and can be expected to have effects such as improvement of the skin surface state and suppression of growth of harmful bacteria.
  • cultivation it is suitably set according to conditions, such as the kind of useful microbe used as the objective of isolation
  • those that are isolated for each strain and purely cultured may be mixed and used at a predetermined ratio at the time of manufacturing the skin care composition. You may culture in the state.
  • composition for skin care live bacteria of useful bacteria selectively grown as described above may be used directly, but long-term storage is possible in a state containing the live bacteria. Because it is difficult, prepare asphyxia of useful bacteria or dry cells of useful bacteria, and restore the useful bacteria by dispersing in a base containing water just before use, for skin care containing useful bacteria A composition may be prepared.
  • the base material of the skin care composition is not particularly limited as long as useful bacteria can survive and / or grow therein, and any base such as lotion, milky lotion, serum, gel, cream, lotion, spray, etc.
  • Special care products such as cosmetics and packs, hair tonics, hair lotions, hair growth agents, hair treatments, hair conditioners, hair packs, hair dyes and other scalp care products or hair cosmetics can be used.
  • About the compounding quantity of the useful microbe per unit volume it selects suitably according to a base material, the kind of useful microbe, etc.
  • any known method can be used without particular limitation as a method for producing the dried cells, and specific examples thereof include a freeze drying method and a hot air drying method.
  • a freeze drying method when producing dry cells by freeze-drying, useful bacteria are dispersed in a dispersion medium (usually water is used) in the presence of an appropriate protective agent such as skim milk or soy milk, and liquid nitrogen or the like is used. After freezing, remove water under reduced pressure with a freeze dryer. The dried cells thus obtained can be sealed and stored in a sterilized ampoule or the like.
  • the composition for skin care is a useful cell.
  • these may be included instead of viable bacteria.
  • Proportion of useful bacteria in the normal flora of skin by supplying a substance that specifically promotes the growth of useful bacteria on the skin surface of the individual instead of supplying live bacteria. This is because it is possible to increase the skin and keep the skin healthy.
  • the skin care composition is a skin cleanser such as a shampoo, body shampoo, or head spa detergent containing a surfactant. It may be.
  • the composition for skin care contains viable bacteria of useful bacteria, it may contain any additive usually used in cosmetics and the like as long as its production and / or growth is not inhibited.
  • additives include flavoring agents, preservatives, antioxidants, bactericides (limited to those having no or weak antibacterial activity against useful bacteria), emulsifiers, stabilizers, and the like.
  • the composition for skin care may further contain a substance that specifically promotes the growth of useful bacteria.
  • the skin care composition By administering (returning) the skin care composition containing any one or more of the cells of the useful bacteria thus obtained, the bacterial cell components and the useful bacterial product to the individual's skin, (The site to be administered (returned) may be the same as or different from the site from which the skin resident bacteria were collected).
  • Useful bacteria adapted to can grow rapidly on the skin surface and improve the health of the skin.
  • the skin care composition can be administered in the form of a skin care composition such as application of liquids such as lotion, milky lotion, lotion, spraying of sprays, application of cream, gel, etc. Any method can be selected. Administration may be performed using fingers or the like, but may also be performed using a device such as a spray or an applicator.
  • the administration interval and dosage per dose of the skin care composition can be adjusted as appropriate according to the type of useful bacteria, the site to be administered, the health condition of the skin, etc., but the bacteria are reliably fixed on the skin surface. In order to achieve this, it is preferable to administer continuously.
  • a skin care composition containing this is administered (returned) to the same individual.
  • it may be administered to the skin surface of an individual different from the individual from whom the bacteria were collected.
  • collected from several persons may be included. It may be administered.
  • Example 1 Separation and pure culture of Staphylococcus epidermidis from resident skin bacterium and production of dry cells
  • Collection of resident skin bacterium The following operation was performed while wearing sterile gloves. After washing, a polycarbonate cylinder (inner diameter 25 mm ⁇ ) sterilized in an autoclave is lightly pressed onto the skin surface of the subject's forehead, and the exposed skin surface inside the cylinder is sterilized phosphate buffered saline (PBS). Wipe with a sterile cotton swab soaked for 20 seconds. The cylinder was released and the moisture remaining on the skin surface was wiped off with a sterile cotton swab.
  • PBS phosphate buffered saline
  • Preliminary culture 100 ⁇ L of the bacterial solution obtained as described above was added to a microtube containing 900 ⁇ L of PBS and vortexed to prepare a 10-fold diluted solution. The same operation was repeated using a diluted solution instead of the bacterial solution to prepare a 100 to 100,000-fold diluted solution. 50 ⁇ L of each of the obtained dilutions was added on trypticase soy agar medium (TS medium) and a selective medium for Staphylococcus aureus (hereinafter referred to as “selective medium”), and uniformly spread, and cultured at 37 ° C. for 48 hours. It was.
  • TS medium trypticase soy agar medium
  • selective medium a selective medium for Staphylococcus aureus
  • Example 2 Clinical study Using 21 females in their 20s to 50s as subjects, separation was performed from the skin resident bacteria collected from the skin (forehead) of the subject on the first day of the test using the procedure described in Example 1. In addition, the effect of administration (returning) of Staphylococcus epidermidis derived from the self-resident resident bacteria on purely cultured skin on the number of staphylococcus epidermidis on the skin surface and the water content of the epidermis was examined.
  • the number of Staphylococcus epidermidis was measured by the method described in [1] and [2] of Example 1, and among the colonies of skin resident bacteria cultured after harvesting from the skin surface of the forehead, [3] of Example 1 This was done by counting the number of those identified as Staphylococcus epidermidis colonies by the method described. For the latter measurement, a cutometer MPA580 (skin viscoelasticity measuring device: manufactured by C + K, Germany) and a Corneometer probe were used (first course).
  • FIG. 1 shows the change over time in the number of Staphylococcus epidermidis (expressed as “relative number of skin-skins”) when the number of Staphylococcus epidermidis before the start of clinical trials in each group is 1.
  • the number of Staphylococcus epidermidis on the skin surface is significantly increased by administering (returning) Staphylococcus epidermidis derived from its own skin resident bacteria. When it stopped, it turned to decrease.
  • the number of Staphylococcus epidermidis on the skin surface is almost constant while the placebo is administered, whereas it is significant when switching to the returning operation of Staphylococcus epidermidis derived from its own skin resident bacteria.
  • staphylococcus epidermidis derived from its own skin resident bacteria is administered (returned), and staphylococcus epidermidis reliably settles on the skin surface.
  • staphylococcus epidermidis derived from its own skin resident bacteria
  • staphylococcus epidermidis reliably settles on the skin surface.
  • FIG. 2 shows the amount of skin moisture (relative value of skin moisture) in the forehead before and after the end of the first cool in the first group and the second group.
  • the first group it was confirmed that the amount of water in the epidermis was significantly increased by administering (returning) Staphylococcus epidermidis derived from the resident bacteria of the skin for 3 to 4 weeks in the first course.
  • the second group it was observed that the water content of the epidermis was almost constant throughout the first course.

Abstract

Provided are: a novel and safe beauty treatment method which can cope with the individual variation of skin environments readily, has little adverse impacts such as adverse side effects, and enables the selective proliferation of a useful bacterium to thereby keep the normal bacterial skin flora healthy; a skin care composition; and a dried bacterium cell which can be used suitably for the production of the skin care composition. A beauty treatment method comprising a step of collecting bacteria inhabiting the surface of the skin of a human body, a step of selectively proliferating at least one useful bacterium that can be proliferated on the surface of the skin of a human body and can improve the health state of the skin among the collected bacteria, and a step of administering a composition containing at least one selected from the group consisting of a cell of the proliferated useful bacterium, a cell component of the useful bacterium and a substance produced by the useful bacterium onto the skin of a human body; and a skin care composition containing a useful bacterium that has been proliferated selectively in the above-mentioned manner and/or a substance produced by the useful bacterium.

Description

美容方法、スキンケア用組成物、菌体および乾燥菌体Cosmetic method, skin care composition, fungus body and dried fungus body
 本発明は、皮膚環境の個人差に関わりなく、万人に適用可能であり、かつ副作用等の殆どない美容方法、スキンケア用組成物ならびにその製造に好適に用いられる菌体および乾燥菌体に関する。 The present invention relates to a cosmetic method, a skin care composition that can be applied to all persons and has almost no side effects regardless of individual differences in skin environment, and a microbial cell and a dry microbial cell suitably used for the production thereof.
 人間の皮膚の表面には数十種類程度の皮膚常在菌が生息していることが知られている。皮膚常在菌の中には、黄色ブドウ球菌等のように人体に有害なものも存在する一方、皮膚状態を健全に保つ上で有用な有用菌も存在しており、常在菌を正常な状態に保つことが皮膚または皮膚表面の状態の改善のために有用である。例えば、表皮ブドウ球菌(Staphylococcus epidermidis)は、グリセリンを産生することにより、皮膚の保湿機能やバリア機能の維持に大きく寄与していると共に、有機酸を産生し、皮膚の表面を弱酸性に保つことで、有害菌の繁殖を抑制する上でも大きな役割を果たしている(例えば、非特許文献1参照)。さらに、表皮ブドウ球菌は、有害菌である黄色ブドウ球菌の生育を阻害する抗菌ペプチドを産生する。 It is known that dozens of types of skin resident bacteria live on the surface of human skin. Some of the skin resident bacteria are harmful to the human body, such as Staphylococcus aureus, while other useful bacteria are useful for maintaining a healthy skin condition. Maintaining the condition is useful for improving the condition of the skin or skin surface. For example, Staphylococcus epidermidis contributes significantly to maintaining the skin's moisturizing function and barrier function by producing glycerin, and also produces organic acids and keeps the skin surface weakly acidic. Therefore, it plays a major role in suppressing the growth of harmful bacteria (see Non-Patent Document 1, for example). Furthermore, Staphylococcus epidermidis produces an antimicrobial peptide that inhibits the growth of Staphylococcus aureus, which is a harmful bacterium.
 食中毒やインフルエンザ等の感染症の予防や、ニキビ等の皮膚疾患の予防のために、皮膚の表面を清浄に保ち、有害菌の繁殖を抑制することが有用であるとされている。そのため、石けん等の洗浄剤が用いられている。しかしながら、これらの洗浄剤を使いすぎると、セラミド等の皮膚の保湿成分が失われてしまうと共に、有用菌をも死滅させてしまうおそれがあり、却って逆効果となる場合がある。 In order to prevent infectious diseases such as food poisoning and influenza and skin diseases such as acne, it is said that it is useful to keep the surface of the skin clean and suppress the growth of harmful bacteria. Therefore, detergents such as soap are used. However, if these detergents are used too much, the skin moisturizing components such as ceramide may be lost and useful bacteria may be killed, which may be counterproductive.
 皮膚常在菌叢に占める各菌種の存在割合は、種々の要因により影響を受けるが、有用菌の生育が何らかの要因により阻害されると、有害菌が優勢となり、各種疾患を引き起こすおそれがある。そこで、皮膚常在菌叢の健全化のために、有用菌に影響を与えず有害菌のみに対し選択的に殺菌作用または静菌作用を示す化合物についての研究開発が盛んに行われている。例えば、特許文献1には、皮膚常在菌の中でも増殖したアクネ菌(Propionibacterium属)にだけ効果的に作用し、好気性菌には作用しない、皮膚常在菌のバランスを健常な状態にする皮膚常在菌正常化剤として、オウレン抽出物を有効成分とするものが開示されている。特許文献2には、複数の糖がβ結合した水溶性糖類を含有する皮膚常在菌叢改善剤が開示されている。特許文献3には、黄色ブドウ球菌を静菌・殺菌し、表皮ブドウ球菌を増殖させる活性成分としてヒノキチオール配糖体を含有する皮膚常在菌の生態系バランス調整剤が開示されている。特許文献4には、表皮ブドウ球菌に対しては殺菌作用を示さず、黄色ブドウ球菌に対しては殺菌若しくは増殖抑制作用を有する有効成分として、キダチキンバイ及びタコノキ属植物抽出物から選択される1種または2種以上と、ニガリを含有する皮膚常在菌の生態系バランス調整剤が開示されている。 The existence ratio of each bacterial species in the resident skin flora is affected by various factors, but if the growth of useful bacteria is inhibited by any factor, harmful bacteria may become dominant and cause various diseases. . Therefore, research and development have been actively conducted on compounds that have a bactericidal action or a bacteriostatic action selectively only against harmful bacteria without affecting useful bacteria in order to improve the normal skin flora. For example, Patent Document 1 discloses that the balance of skin resident bacteria that works effectively only on the grown Acne bacteria (genus Propionibacterium) among the skin resident bacteria and does not act on aerobic bacteria is healthy. As a skin normal bacteria normalizing agent, what has an auren extract as an active ingredient is disclosed. Patent Document 2 discloses a skin resident flora-improving agent containing a water-soluble saccharide in which a plurality of sugars are β-bonded. Patent Document 3 discloses an ecosystem balance regulator for skin resident bacteria containing hinokitiol glycoside as an active ingredient for bacteriostasis and sterilizing Staphylococcus aureus and causing Staphylococcus epidermidis to grow. Patent Document 4 discloses one kind selected from a plant extract of the genus Kidney chicken and the genus Taconoki as an active ingredient having no bactericidal action against Staphylococcus epidermidis and having a bactericidal or growth-inhibiting action against Staphylococcus aureus. Or the ecosystem balance regulator of skin resident bacteria containing 2 or more types and bittern is disclosed.
特開2010-202604号公報JP 2010-202604 A 特開2008-50322号公報JP 2008-50322 A 特開2007-246411号公報JP 2007-246411 A 特開2007-153800号公報JP 2007-153800 A
 しかしながら、外在性の化合物を投与することにより皮膚常在菌叢の健全化を図るという特許文献1~4の方法では、有害菌における薬剤耐性の獲得や、個人毎の皮膚環境の相違等により皮膚常在菌叢を構成する各菌種が変異を受け、薬剤感受性が変化した場合等に健全化効果を発揮できなくなるおそれがある。このような変化に応じて最適な薬剤を、多数の候補化合物の中からオーダーメイド的に選択することは大変な困難を伴う。 However, in the methods of Patent Documents 1 to 4 in which the skin resident flora is sounded by administering an exogenous compound, the drug resistance in harmful bacteria is acquired, the skin environment of each individual is different, etc. If the bacterial species constituting the skin resident flora are mutated and the drug susceptibility changes, there is a possibility that the soundening effect cannot be exhibited. It is extremely difficult to select an optimal drug according to such changes from a large number of candidate compounds in a custom-made manner.
 本発明は上記課題に鑑みてなされたものであり、皮膚環境の個人差に容易に対応可能で、副作用等の悪影響が少なく、有用菌を選択的に増殖させることにより皮膚常在菌叢の健全化を図ることが可能な、新規かつ安全な美容方法、スキンケア用組成物およびその製造に好適に用いられる乾燥菌体を提供することにある。 The present invention has been made in view of the above problems, can easily cope with individual differences in the skin environment, has little adverse effects such as side effects, and healthy growth of the normal skin flora by selectively growing useful bacteria. It is an object of the present invention to provide a novel and safe cosmetic method, a skin care composition, and a dry cell body suitably used for the production thereof.
 すなわち、本発明は、下記[1]~[7]記載の美容方法、[8]~[12]記載のスキンケア用組成物、[13]~[17]記載の菌体および[18]の乾燥菌体を提供することにより上記課題の解決を図るものである。
 [1] ヒトの皮膚表面に生息する細菌を採取する工程と、前記細菌のうち、ヒトの皮膚表面で増殖し、皮膚の健康状態を改善させる1または複数種の有用菌を選択的に増殖させる工程と、前記増殖させた有用菌の菌体、菌体成分および前記有用菌の産生物質からなる群より選択される1または複数を含む組成物をヒトの皮膚に投与する工程とを有する美容方法。
 [2] 前記投与する工程において、前記細菌を採取したのと同一のヒト個体に前記組成物の投与(戻し)を行う上記[1]記載の美容方法。
 [3] 前記細菌が皮膚常在菌である上記[1]または[2]記載の美容方法。
 [4] 前記1または複数種の有用菌を選択的に増殖させる工程が、
 採取した前記細菌を培地上で培養する予備培養工程と、
 前記培養した細菌から前記有用菌を選抜する選抜工程と、
 前記選抜した有用菌を培養する培養工程とを含む上記[1]から[3]のいずれか1項記載の美容方法。
 [5] 前記細菌がヒトの健全な状態の皮膚表面に生息するものである上記[1]から[4]のいずれか1項記載の美容方法。
 [6] 前記有用菌がコアグラーゼ陰性ブドウ球菌である上記[1]から[5]のいずれか1項記載の美容方法。
 [7] 前記有用菌が表皮ブドウ球菌(Staphylococcus epidermidis)である上記[6]記載の美容方法。
 [8] ヒトの皮膚表面から採取した皮膚常在菌より分離し選択的に増殖させた、ヒトの皮膚表面で増殖し、皮膚の健康状態を改善させる1または複数種の有用菌の菌体、菌体成分および前記有用菌の産生物質からなる群より選択される1または複数を含むスキンケア用組成物。
 [9] 前記細菌が皮膚常在菌である上記[8]記載のスキンケア用組成物。
 [10] 前記細菌が、ヒトの健全な状態の皮膚表面に生息するものである上記[8]または[9]記載のスキンケア用組成物。
 [11] 前記有用菌がコアグラーゼ陰性ブドウ球菌である上記[8]から[10]のいずれか1項記載のスキンケア用組成物。
 [12] 前記有用菌が表皮ブドウ球菌(Staphylococcus epidermidis)である上記[11]記載のスキンケア用組成物。
 [13] ヒトの皮膚表面から採取した皮膚常在菌のうち、ヒトの皮膚表面で増殖し、皮膚の健康状態を改善させる1または複数種の有用菌を選択的に増殖させて得られる菌体。
 [14] 前記細菌が皮膚常在菌である上記[13]記載の菌体。
 [15] 前記細菌がヒトの健全な状態の皮膚表面に生息するものである上記[13]または[14]記載の菌体。
 [16] 前記有用菌がコアグラーゼ陰性ブドウ球菌である上記[13]から[15]のいずれか1項記載の菌体。
 [17] 前記有用菌が表皮ブドウ球菌(Staphylococcus epidermidis)である上記[16]記載の菌体。
 [18] 上記[13]から[17]のいずれか1項記載の菌体を乾燥させて得られる乾燥菌体。
That is, the present invention provides a cosmetic method described in [1] to [7] below, a skin care composition described in [8] to [12], a fungus body described in [13] to [17], and a dried [18]. The solution of the above-described problem is achieved by providing the bacterial cells.
[1] A step of collecting bacteria that inhabit the human skin surface, and one or more useful bacteria that grow on the human skin surface and improve skin health among the bacteria are selectively grown. And a step of administering to the human skin a composition comprising one or more selected from the group consisting of cells of the proliferated useful bacteria, bacterial cell components, and substances produced by the useful bacteria .
[2] The cosmetic method according to the above [1], wherein in the administration step, the composition is administered (returned) to the same human individual from whom the bacteria have been collected.
[3] The cosmetic method according to [1] or [2], wherein the bacterium is a resident skin bacterium.
[4] The step of selectively growing the one or more kinds of useful bacteria comprises:
A pre-culturing step of culturing the collected bacteria on a medium;
A selection step of selecting the useful bacteria from the cultured bacteria;
The cosmetic method according to any one of [1] to [3], further comprising a culture step of culturing the selected useful bacteria.
[5] The cosmetic method according to any one of [1] to [4], wherein the bacteria live on the skin surface of a healthy human being.
[6] The cosmetic method according to any one of [1] to [5], wherein the useful bacteria are coagulase-negative staphylococci.
[7] The cosmetic method according to [6] above, wherein the useful bacterium is Staphylococcus epidermidis.
[8] One or a plurality of useful bacterial cells that are isolated from the skin resident bacteria collected from the human skin surface and selectively proliferated, grow on the human skin surface, and improve the health of the skin, A composition for skin care comprising one or more selected from the group consisting of bacterial cell components and substances produced by the useful bacteria.
[9] The skin care composition according to the above [8], wherein the bacteria are skin resident bacteria.
[10] The skin care composition according to the above [8] or [9], wherein the bacteria live on the skin surface of a healthy human state.
[11] The skin care composition according to any one of [8] to [10], wherein the useful bacteria are coagulase-negative staphylococci.
[12] The skin care composition according to the above [11], wherein the useful bacterium is Staphylococcus epidermidis.
[13] Among cells resident in the skin collected from the surface of human skin, cells obtained by selectively growing one or more useful bacteria that grow on the surface of human skin and improve the health of the skin .
[14] The bacterial cell according to [13] above, wherein the bacterium is a resident skin bacterium.
[15] The bacterial cell according to the above [13] or [14], wherein the bacterium lives on the skin surface of a healthy human state.
[16] The microbial cell according to any one of [13] to [15], wherein the useful bacterium is coagulase-negative staphylococci.
[17] The microbial cell according to [16] above, wherein the useful bacterium is Staphylococcus epidermidis.
[18] A dry cell obtained by drying the cell according to any one of [13] to [17].
 ヒトの皮膚より採取した細菌、特に皮膚常在菌は、ヒトに固有の皮膚環境下で特に増殖しやすい。そのため、ヒトの皮膚表面より採取した細菌から選択的に増殖させた1または複数種の有用菌、あるいはその増殖を促進させる有用菌の菌体成分または産生物質を含む組成物をヒトの皮膚表面に投与すると、有用菌が皮膚表面で優勢となることにより、有害菌の繁殖を有効に抑制でき、ひいては皮膚常在菌叢のバランスを適切に保つことができる。その結果、皮膚の健康状態を確実に保持または改善することができる。したがって、本発明により提供される美容方法およびスキンケア用組成物は、皮膚状態を健全に保つ上で有用である。また、本発明の美容方法およびスキンケア用組成物では、薬剤を使用しないため、安全であると共に、副作用等の悪影響が少ないという利点を有している。 Bacteria collected from human skin, in particular skin resident bacteria, are particularly prone to growth in human-specific skin environments. Therefore, a composition containing one or a plurality of useful bacteria selectively grown from bacteria collected from the surface of human skin, or a cell component or product of useful bacteria that promotes the growth is applied to the human skin surface. When administered, useful bacteria become dominant on the skin surface, so that the growth of harmful bacteria can be effectively suppressed, and thus the balance of the normal flora of the skin can be appropriately maintained. As a result, the health condition of the skin can be reliably maintained or improved. Therefore, the cosmetic method and the skin care composition provided by the present invention are useful for keeping the skin condition healthy. Further, the cosmetic method and the skin care composition of the present invention have the advantages that they are safe and have few adverse effects such as side effects because no drug is used.
 特に、個人の皮膚より採取した細菌、特に皮膚常在菌は、皮膚環境の個人差に適応しており、その個人に固有の皮膚環境下で特に増殖しやすい。そのため、個人の皮膚表面より採取した細菌から有用菌のみを選択的に増殖させたものをその個人の皮膚表面に投与する(戻す)と、皮膚環境の個人差に関わりなく、有用菌が皮膚表面で優勢となることにより、有害菌の繁殖をより有効に抑制でき、ひいては皮膚常在菌叢のバランスをより適切に保つことができる。 In particular, bacteria collected from the skin of an individual, especially skin resident bacteria, are adapted to individual differences in the skin environment and are particularly prone to proliferate in the skin environment unique to that individual. For this reason, when bacteria that have been selectively grown from bacteria collected from the skin surface of the individual are administered (returned) to the skin surface of the individual, the useful bacteria are exposed to the skin surface regardless of individual differences in the skin environment. By being dominant, it is possible to more effectively suppress the growth of harmful bacteria, and thus to keep the balance of the normal skin flora more appropriately.
自己の皮膚常在菌由来の表皮ブドウ球菌の戻し作業が皮膚表面の表皮ブドウ球菌数に及ぼす影響を示すグラフである。It is a graph which shows the influence which the returning operation | work of the dermal staphylococci derived from an own skin resident bacteria has on the number of Staphylococcus epidermidis on the skin surface. 自己の皮膚常在菌由来の表皮ブドウ球菌の戻し作業が表皮水分量に及ぼす影響を示すグラフである。It is a graph which shows the influence which the return | restoration work of staphylococcus epidermidis derived from an own skin resident microbe has on the amount of epidermis moisture.
 以下、本発明の実施形態(あくまで例示に過ぎず、本発明の範囲を限定するものではない。)について説明する。
 本発明の一実施の形態に係る美容方法(以下、「美容方法」と略称する場合がある。)は、個人(ヒトの個体)の皮膚表面からその表面に生息する皮膚常在菌(細菌の一例)を採取する工程と、皮膚常在菌のうち、個人の皮膚表面で増殖し、皮膚の健康状態を改善させる1または複数種の有用菌を選択的に増殖させる工程と、増殖させた有用菌の菌体、菌体成分および有用菌の産生物質からなる群より選択される1または複数を含むスキンケア用組成物を個人の皮膚に投与する(戻す)工程とを有している。
Hereinafter, an embodiment of the present invention (which is merely an example and does not limit the scope of the present invention) will be described.
A cosmetic method according to an embodiment of the present invention (hereinafter may be abbreviated as “cosmetic method”) includes a skin resident bacteria (bacteria of bacteria) that inhabit the surface of an individual (human individual). An example), a step of selectively growing one or more kinds of useful bacteria that grow on the skin surface of individuals and improve the health of the skin among the skin resident bacteria, Administering (returning) a skin care composition containing one or more selected from the group consisting of bacterial cells, bacterial cell components and useful bacterial product to the skin of an individual.
 美容方法に用いられるスキンケア用組成物は、個人の皮膚表面から採取した細菌より分離し選択的に増殖させた1または複数種の有用菌の菌体、菌体成分および有用菌の産生物質からなる群より選択される1または複数を含んでおり、個人の皮膚よりその表面に生息する細菌を採取する工程と、採取した細菌のうち1または複数種の有用菌のみを選択的に増殖させる工程とを含む方法により製造される。以下、スキンケア用組成物の製造に関する各工程についてより具体的に説明する。 A composition for skin care used in a cosmetic method comprises one or a plurality of types of useful bacteria isolated from bacteria collected from the surface of an individual's skin and selectively proliferated, components of the cells, and products of useful bacteria Including one or more selected from the group and collecting bacteria living on the surface of the individual's skin, and selectively growing only one or more useful bacteria from the collected bacteria; It is manufactured by the method containing. Hereafter, each process regarding manufacture of the composition for skin care is demonstrated more concretely.
(1)細菌の採取
 皮膚の表面には数十種類の皮膚常在菌を始めとする細菌が存在しているが、スキンケア用組成物の製造に用いられる細菌としては、皮膚の状態を健全に保つ上で有用なものであれば、これらのうち任意のものを単独で、あるいは任意の2以上のものを適宜組み合わせて用いてもよい。スキンケア用組成物の製造に好適に用いられる細菌としては、ヒトの皮膚常在菌が挙げられ、その具体例として、表皮ブドウ球菌(Staphylococcus epidermidis)が挙げられる。
(1) Bacterial collection Bacteria such as dozens of skin resident bacteria are present on the surface of the skin, but as a bacterium used in the production of a skin care composition, the skin condition is healthy. Any one of these may be used alone, or any two or more of them may be used in appropriate combination as long as they are useful for maintenance. Examples of bacteria suitably used in the production of a skin care composition include human skin resident bacteria, and specific examples thereof include Staphylococcus epidermidis.
 皮膚常在菌等の各種細菌は、全身の皮膚表面に存在するが、顔や脇の下等の表面に特に多く存在する。そのため、これらの部位から採取することが好ましい。特に、化粧品としてスキンケア用組成物を使用する場合には、顔の皮膚表面から細菌、例えば皮膚常在菌を採取することが好ましい。健康な皮膚表面では皮膚常在菌のバランスも適切に保たれていると考えられることから、皮膚常在菌の採取は健康な(健全な状態の)皮膚表面から行うことが好ましい。 Various bacteria such as skin resident bacteria are present on the skin surface throughout the body, but are particularly abundant on the surface such as the face and armpits. Therefore, it is preferable to collect from these sites. In particular, when a skin care composition is used as a cosmetic, it is preferable to collect bacteria such as skin resident bacteria from the skin surface of the face. Since it is considered that the balance of skin resident bacteria is appropriately maintained on the healthy skin surface, it is preferable to collect the skin resident bacteria from the healthy (healthy) skin surface.
 細菌の採取は、皮膚表面からの細菌の採取および任意の菌株の単離が可能な任意の方法を用いて行うことができる。例えば、必要に応じて生理食塩水や緩衝液で湿らせ、滅菌した綿棒、ガーゼ、不織布、紙、スポンジ等の任意の器具で皮膚表面を拭うことにより採取する方法、滅菌した寒天培地を皮膚表面に圧着して細菌を皮膚表面から培地の表面に転写する方法、水、生理食塩水等の液体を皮膚表面に接触させ、皮膚表面に存在する細菌を液体中に懸濁させ液体と共に回収する方法等が挙げられる。採取した細菌に含まれる菌種およびそれらの数の比は、皮膚の健康状態を診断するための指標ともなるため、細菌の採取は、皮膚上の一定の面積から行うことが好ましい。滅菌綿棒で皮膚表面を拭う方法により細菌を採取する場合、滅菌綿棒で拭う面積を一定に保つために、合成樹脂やガラス等からなり、両端が開口した円筒状、楕円筒状、または角柱状の採取具を皮膚に軽く密着させ、開口の内部をくまなく拭うことにより細菌を採取してもよい。このような方法により、常に所定の面積範囲内の皮膚表面から細菌を採取することができる。 Bacteria can be collected using any method capable of collecting bacteria from the skin surface and isolating any strain. For example, a method of collecting by wiping the skin surface with any instrument such as a cotton swab, gauze, non-woven fabric, paper, sponge etc. A method of transferring bacteria from the skin surface to the surface of the culture medium by pressing onto the surface of the medium, a method of bringing a liquid such as water or physiological saline into contact with the skin surface, suspending the bacteria present on the skin surface in the liquid, and collecting it together with the liquid Etc. Since the bacterial species contained in the collected bacteria and the ratio of the numbers also serve as an index for diagnosing the health condition of the skin, it is preferable to collect the bacteria from a certain area on the skin. When collecting bacteria by wiping the skin surface with a sterile cotton swab, in order to keep the area wiped with a sterile cotton swab constant, it is made of a synthetic resin, glass, etc., open at both ends, cylindrical, elliptical cylinder, or prismatic Bacteria may be collected by lightly adhering the collection tool to the skin and wiping all over the opening. By such a method, bacteria can always be collected from the skin surface within a predetermined area range.
 一方、滅菌した寒天培地を皮膚表面に圧着する方法を用いて細菌を採取する場合には、所定の面積(半径)を有する培地を用いることにより、常に一定の面積範囲内の皮膚表面から細菌を採取することができる。細菌の採取に用いることができる培地は特に限定されないが、皮膚常在菌の採取に用いられる培地の具体例としては、一般生菌用の標準寒天培地やトリプチケースソイ寒天培地、卵黄加マンニット食塩培地や食塩卵寒天培地等のブドウ球菌用の選択分離培地が挙げられる。なお、細菌の採取に用いられる培地は、皮膚表面に接触させるため、アレルゲンとして作用する可能性のある物質を含まない組成の培地を用いることが好ましい。 On the other hand, when bacteria are collected using a method in which a sterilized agar medium is pressed against the skin surface, the bacteria are always removed from the skin surface within a certain area by using a medium having a predetermined area (radius). Can be collected. The medium that can be used for collecting bacteria is not particularly limited, but specific examples of the medium used for collecting skin resident bacteria include standard agar medium, trypticase soy agar medium for normal living bacteria, egg yolk man Examples include selective separation media for staphylococci such as knit saline and salted egg agar. In addition, since the culture medium used for collection | recovery of bacteria is made to contact the skin surface, it is preferable to use the culture medium of the composition which does not contain the substance which may act as an allergen.
(2)有用菌の選択的増殖
 上記のようにして皮膚表面から採取した細菌には、有用菌も有害菌も含まれている。これらのうち、所望の1または複数種の有用菌のみを選択的に増殖させる。選択的な増殖の方法としては、所望の有用菌のみを分離後培養する方法、所望の有用菌のみが増殖する条件下で培養を行う方法があり、いずれの方法を用いてもよい。
(2) Selective growth of useful bacteria The bacteria collected from the skin surface as described above include both useful bacteria and harmful bacteria. Of these, only one or more desired useful bacteria are selectively grown. As selective growth methods, there are a method in which only desired useful bacteria are isolated and cultured, and a method in which culture is performed under conditions in which only desired useful bacteria are grown, and either method may be used.
 前者の方法の一例として、有用菌を選択的に増殖させる工程は、下記の(i)~(iii)の工程を含んでいてもよい。
 (i)採取した細菌を培地上で培養する予備培養工程
 (ii)培養した細菌の同定を行い、有用菌を選抜する選抜工程
 (iii)選抜した有用菌を培養する培養工程
As an example of the former method, the step of selectively growing useful bacteria may include the following steps (i) to (iii).
(I) Preliminary culture process for culturing collected bacteria on medium (ii) Selection process for identifying cultured bacteria and selecting useful bacteria (iii) Culture process for culturing selected useful bacteria
(i)予備培養工程
 滅菌綿棒等を用いて採取した細菌は、リン酸緩衝生理食塩水(PBS)等の希釈液を用いて所定の倍率(例えば10~100,000倍)に希釈し、培養用の培地表面に塗布後、培養を行う。培養条件は、分離の目的とする有用菌の種類や使用する培地等の条件に応じて適宜設定される。
(I) Pre-culture process Bacteria collected using a sterile cotton swab, etc. are diluted with a diluent such as phosphate buffered saline (PBS) at a predetermined magnification (eg, 10 to 100,000 times) and cultured. After applying to the surface of the culture medium, culture is performed. The culture conditions are appropriately set according to the conditions of the useful bacteria to be separated and the medium to be used.
 なお、培地を皮膚表面に圧着することにより細菌の採取を行った場合、予備培養工程は採取を行った培地の表面でそのまま行ってもよいが、培地表面から滅菌綿棒等を用いて再採取した細菌を希釈し、培養用の培地表面に塗布後、上記と同様の手順を用いて予備培養を行ってもよい。培養用の培地としては、トリプチケースソイ寒天培地(TS培地)等の一般細菌用の培地や、上述のブドウ球菌用の選択分離用培地等が挙げられる。 In addition, when bacteria are collected by pressing the medium on the skin surface, the pre-culture process may be performed as it is on the surface of the collected medium, but it is re-collected from the medium surface using a sterile cotton swab etc. After the bacteria are diluted and applied to the surface of the culture medium, pre-culture may be performed using the same procedure as described above. Examples of the culture medium include a medium for general bacteria such as trypticase soy agar medium (TS medium), a selective separation medium for the aforementioned staphylococci, and the like.
(ii)選抜工程
 上記の予備培養工程で培養した細菌について、菌種の同定を行い、有用菌の選抜を行う。選抜工程は、任意の公知の方法を用いて行うことができるが、例えば、下記のような手順で行われる。まず、培地の目視観察を行い、培地上に形成されたコロニー数のカウントを行うと共に、可能な場合には外観による予備分類を行う。次いで、個々のコロニーまたはそのうちの代表的ないくつかについて、菌種の同定を行う。例えば、表皮ブドウ球菌の場合には、顕微鏡観察、グラム染色およびコアグラーゼ活性を組み合わせることにより同定を行う。特に、表皮ブドウ球菌は、黄色ブドウ球菌等の病原性菌と異なりコアグラーゼ陰性(CNS)であるため、コアグラーゼ活性の測定は、黄色ブドウ球菌との識別上重要である。
(Ii) Selection process About the bacteria culture | cultivated at said preliminary culture process, a bacterial species is identified and a useful microbe is selected. Although a selection process can be performed using arbitrary well-known methods, it is performed in the following procedures, for example. First, the medium is visually observed, the number of colonies formed on the medium is counted, and, if possible, preliminary classification by appearance is performed. Then, bacterial species are identified for individual colonies or some representative of them. For example, in the case of Staphylococcus epidermidis, identification is performed by combining microscopic observation, Gram staining, and coagulase activity. In particular, Staphylococcus epidermidis is coagulase negative (CNS) unlike pathogenic bacteria such as Staphylococcus aureus. Therefore, measurement of coagulase activity is important for discrimination from Staphylococcus aureus.
(iii)培養工程
 上記のようにして皮膚常在菌等の細菌から選抜(分離)された有用菌を培養する。培養は、任意の公知の方法を用いて行うことができる。このようにして得られる有用菌は、皮膚常在菌を採取した個人の皮膚表面の環境に適応していると考えられるため、スキンケア用組成物に含有させて個人の皮膚表面に投与する(戻す)ことにより、皮膚表面で優勢に増殖し、それに伴う皮膚表面の状態の改善や有害菌の増殖抑制等の効果が期待できる。培養に使用される培地や培養条件については、予備培養工程の場合と同様、分離の目的とする有用菌の種類や使用する培地等の条件に応じて適宜設定される。なお、複数の有用菌を選抜した場合、菌株ごとに分離し、純粋培養したものを、スキンケア用組成物の製造時に所定の割合で混合して用いてもよいが、複数種の有用菌を混合した状態で培養してもよい。
(Iii) Culture process The useful bacteria selected (separated) from bacteria such as skin resident bacteria are cultured as described above. Culturing can be performed using any known method. The useful bacteria obtained in this way are considered to be suitable for the environment of the skin surface of the individual from whom the skin resident bacteria were collected. Therefore, they are contained in the skin care composition and administered (returned) to the skin surface of the individual. ), It proliferates predominantly on the skin surface, and can be expected to have effects such as improvement of the skin surface state and suppression of growth of harmful bacteria. About the culture medium and culture conditions used for culture | cultivation, it is suitably set according to conditions, such as the kind of useful microbe used as the objective of isolation | separation, and the culture medium to be used similarly to the case of a preculture process. In addition, when a plurality of useful bacteria are selected, those that are isolated for each strain and purely cultured may be mixed and used at a predetermined ratio at the time of manufacturing the skin care composition. You may culture in the state.
(3)スキンケア用組成物の調製
 スキンケア用組成物の調製に際し、上記のようにして選択的に増殖させた有用菌の生菌を直接用いてもよいが、生菌を含む状態では長期保存が困難であるため、有用菌の仮死状態菌または有用菌の乾燥菌体を調製しておき、使用の直前に水を含む基剤に分散させることにより有用菌を復元し、有用菌を含むスキンケア用組成物を調製してもよい。
(3) Preparation of a composition for skin care In preparing a composition for skin care, live bacteria of useful bacteria selectively grown as described above may be used directly, but long-term storage is possible in a state containing the live bacteria. Because it is difficult, prepare asphyxia of useful bacteria or dry cells of useful bacteria, and restore the useful bacteria by dispersing in a base containing water just before use, for skin care containing useful bacteria A composition may be prepared.
 スキンケア用組成物の基材としては、その中で有用菌が生存および/または増殖できる限りにおいて特に限定されず、化粧水、乳液、美容液、ジェル、クリーム、ローション、スプレー剤等の任意の基礎化粧品、パック等のスペシャルケア品、ヘアトニック、ヘアローション、育毛料、ヘアトリートメント、ヘアコンディショナー、ヘアパック、ヘアダイ等の頭皮ケア用品または頭髪用化粧品等を用いることができる。単位体積あたりの有用菌の配合量については、基材および有用菌の種類等に応じて適宜選択される。 The base material of the skin care composition is not particularly limited as long as useful bacteria can survive and / or grow therein, and any base such as lotion, milky lotion, serum, gel, cream, lotion, spray, etc. Special care products such as cosmetics and packs, hair tonics, hair lotions, hair growth agents, hair treatments, hair conditioners, hair packs, hair dyes and other scalp care products or hair cosmetics can be used. About the compounding quantity of the useful microbe per unit volume, it selects suitably according to a base material, the kind of useful microbe, etc.
 乾燥菌体の作製方法としては、任意の公知の方法を特に制限なく用いることができ、その具体例としては、凍結乾燥法、熱風乾燥法等が挙げられる。例えば、凍結乾燥法により乾燥菌体を作製する場合には、スキムミルクや豆乳等の適当な保護剤の共存下で分散媒(通常、水が用いられる。)に有用菌を分散させ、液体窒素等で凍結後、凍結乾燥機で減圧下水分を除去する。このようにして得られた乾燥菌体は、滅菌したアンプル等に封入し、保管することができる。 Any known method can be used without particular limitation as a method for producing the dried cells, and specific examples thereof include a freeze drying method and a hot air drying method. For example, when producing dry cells by freeze-drying, useful bacteria are dispersed in a dispersion medium (usually water is used) in the presence of an appropriate protective agent such as skim milk or soy milk, and liquid nitrogen or the like is used. After freezing, remove water under reduced pressure with a freeze dryer. The dried cells thus obtained can be sealed and stored in a sterilized ampoule or the like.
 なお、有用菌の死菌体、菌体の超音波破砕物等の菌体成分や有用菌の産生物質が有用菌に対し特異的な増殖促進活性を有する場合、スキンケア用組成物は、有用菌の生菌の代わりにこれらを含んでいてもよい。有用菌の生菌を供給する代わりに、個人の皮膚表面において有用菌の増殖を特異的に促進する物質をその個人の表皮に供給することによっても、皮膚常在菌叢に占める有用菌の割合を増大させ、皮膚の健康状態を健全に保つことが可能だからである。有用菌の生菌の代わりに、有用菌の死菌体や有用菌の産生物質を用いる場合、スキンケア用組成物は、界面活性剤を含むシャンプー、ボディシャンプー、ヘッドスパ用洗浄剤等の皮膚洗浄剤であってもよい。 In addition, when a cell component such as a dead cell of useful bacteria or a sonication product of a cell or a product produced by a useful cell has a specific growth promoting activity against the useful cell, the composition for skin care is a useful cell. These may be included instead of viable bacteria. Proportion of useful bacteria in the normal flora of skin by supplying a substance that specifically promotes the growth of useful bacteria on the skin surface of the individual instead of supplying live bacteria. This is because it is possible to increase the skin and keep the skin healthy. When using dead cells of useful bacteria or substances produced from useful bacteria instead of viable bacteria of useful bacteria, the skin care composition is a skin cleanser such as a shampoo, body shampoo, or head spa detergent containing a surfactant. It may be.
 スキンケア用組成物は、有用菌の生菌を含む場合には、その製造および/または増殖を阻害しないかぎりにおいて、化粧品等に通常用いられる任意の添加剤を含んでいてよい。このような添加剤の具体例としては、着香料、保存料、酸化防止剤、殺菌剤(有用菌に対する抗菌活性のないものまたは弱いものに限る。)、乳化剤、安定剤等が挙げられる。スキンケア用組成物は、有用菌の増殖を特異的に促進する物質をさらに含んでいてもよい。 When the composition for skin care contains viable bacteria of useful bacteria, it may contain any additive usually used in cosmetics and the like as long as its production and / or growth is not inhibited. Specific examples of such additives include flavoring agents, preservatives, antioxidants, bactericides (limited to those having no or weak antibacterial activity against useful bacteria), emulsifiers, stabilizers, and the like. The composition for skin care may further contain a substance that specifically promotes the growth of useful bacteria.
 このようにして得られた有用菌の菌体、菌体成分および有用菌の産生物質のいずれか1または複数を含むスキンケア用組成物を個人の皮膚に投与する(戻す)ことにより有用菌を個人の皮膚に投与する(戻す)(投与する(戻す)部位は、皮膚常在菌の採取を行った部位と同一であっても異なっていてもよい。)ことにより、その個人の皮膚表面の環境に適応している有用菌が皮膚表面で迅速に増殖し、皮膚の健康状態を改善することができる。このような美容方法において、スキンケア用組成物の投与の方法としては、化粧水、乳液、ローション等の液剤の塗布、スプレー剤の噴霧、クリーム、ジェル等の塗布等、スキンケア用組成物の性状に応じた任意の方法を選択することができる。投与は手指等を用いて行ってもよいが、スプレー、アプリケータ等の器具を用いて行ってもよい。スキンケア用組成物の投与間隔および1回当たりの投与量は、有用菌の種類、投与する部位、皮膚の健康状態等に応じて適宜調節することができるが、皮膚表面に有用菌を確実に定着させるためには、継続的に投与を行うことが好ましい。 By administering (returning) the skin care composition containing any one or more of the cells of the useful bacteria thus obtained, the bacterial cell components and the useful bacterial product to the individual's skin, (The site to be administered (returned) may be the same as or different from the site from which the skin resident bacteria were collected). Useful bacteria adapted to can grow rapidly on the skin surface and improve the health of the skin. In such a cosmetic method, the skin care composition can be administered in the form of a skin care composition such as application of liquids such as lotion, milky lotion, lotion, spraying of sprays, application of cream, gel, etc. Any method can be selected. Administration may be performed using fingers or the like, but may also be performed using a device such as a spray or an applicator. The administration interval and dosage per dose of the skin care composition can be adjusted as appropriate according to the type of useful bacteria, the site to be administered, the health condition of the skin, etc., but the bacteria are reliably fixed on the skin surface. In order to achieve this, it is preferable to administer continuously.
 なお、本実施の形態の美容方法では、個人の皮膚から採取した細菌のうち、有用菌のみを選択的に増殖させ、これを含むスキンケア用組成物を同一の個人に投与して(戻して)いるが、細菌を採取した個人とは異なる個人の皮膚表面に投与してもよい。あるいは、複数人から採取した細菌から選択的に増殖させた有用菌(本人から採取した細菌に由来するものを含んでいてもよく、含んでいなくてもよい。)を含むスキンケア用組成物を投与してもよい。 In the cosmetic method of the present embodiment, among bacteria collected from individual skin, only useful bacteria are selectively grown, and a skin care composition containing this is administered (returned) to the same individual. However, it may be administered to the skin surface of an individual different from the individual from whom the bacteria were collected. Or the composition for skin care containing the useful microbe selectively propagated from the bacteria extract | collected from several persons (The thing derived from the bacteria extract | collected from the person may be included) may be included. It may be administered.
 以下、本発明の効果を確認するために行った実施例について説明する。
実施例1:皮膚常在菌からの表皮ブドウ球菌の分離および純粋培養ならびに乾燥菌体の作製
[1]皮膚常在菌の採取
 下記の操作は滅菌手袋を着用した状態で行った。
 洗浄後、オートクレーブ中で滅菌したポリカーボネート製の円筒(内径25mmφ)を被験者の額の皮膚表面に軽く圧着し、円筒の内部に露出した皮膚の表面を滅菌済みのリン酸緩衝生理食塩水(PBS)に20秒間浸した滅菌綿棒で満遍なく拭った。円筒を離し、皮膚表面に残った水分を滅菌綿棒で拭き取った。円筒の皮膚接触面の内側に付着した水分についても同様に滅菌綿棒で拭き取った。滅菌済みのPBSを入れた滅菌済みのチューブ内にこれらの滅菌綿棒(採取者の手が触れた部分は折り取っておく。)を入れ、キャップをして安全キャビネット中に移した。
Examples performed to confirm the effects of the present invention will be described below.
Example 1: Separation and pure culture of Staphylococcus epidermidis from resident skin bacterium and production of dry cells [1] Collection of resident skin bacterium The following operation was performed while wearing sterile gloves.
After washing, a polycarbonate cylinder (inner diameter 25 mmφ) sterilized in an autoclave is lightly pressed onto the skin surface of the subject's forehead, and the exposed skin surface inside the cylinder is sterilized phosphate buffered saline (PBS). Wipe with a sterile cotton swab soaked for 20 seconds. The cylinder was released and the moisture remaining on the skin surface was wiped off with a sterile cotton swab. The water adhering to the inside of the cylindrical skin contact surface was similarly wiped off with a sterile cotton swab. These sterilized cotton swabs were placed in a sterilized tube containing sterilized PBS (the part touched by the collector's hand was folded), capped and transferred into a safety cabinet.
[2]予備培養
 上記の様にして得られた菌液100μLを、900μLのPBSを入れたマイクロチューブに加え、ボルテックスして、10倍希釈液を作製した。菌液の代わりに希釈液を用いて同様の操作を繰り返し、100~100,000倍希釈液を作製した。得られた各希釈液をトリプチケースソイ寒天培地(TS培地)および黄色ブドウ球菌用選択培地(以下「選択培地」という。)上に50μLずつ加え均一に伸ばし、37℃で48時間培養を行った。
[2] Preliminary culture 100 μL of the bacterial solution obtained as described above was added to a microtube containing 900 μL of PBS and vortexed to prepare a 10-fold diluted solution. The same operation was repeated using a diluted solution instead of the bacterial solution to prepare a 100 to 100,000-fold diluted solution. 50 μL of each of the obtained dilutions was added on trypticase soy agar medium (TS medium) and a selective medium for Staphylococcus aureus (hereinafter referred to as “selective medium”), and uniformly spread, and cultured at 37 ° C. for 48 hours. It was.
[3]表皮ブドウ球菌の分離
 TS培地および選択培地上に形成されたコロニーを目視観察し、各コロニーに番号を振った。各コロニーをTS培地および選択培地上で上記[2]と同様の培養条件下で純粋培養した。形成された各コロニーに番号を振り、スライドガラス上に脱イオン水を1滴置き、白金線を用いてコロニーから採取した菌体を分散後、裏からガスバーナーで炙り、スライドガラスの表面に菌体を火炎固定した。これに、クリスタルバイオレット溶液、ヨード液、サフラニン液を順次作用させ、グラム染色を行った。その後、各コロニーに含まれる菌体について、染色性および形態を顕微鏡観察した。併せて、アピ スタフプレートを用いて菌種の同定を行ったところ、表皮ブドウ球菌であることが確認された。
[3] Separation of Staphylococcus epidermidis Colonies formed on the TS medium and the selective medium were visually observed, and each colony was numbered. Each colony was purely cultured on a TS medium and a selective medium under the same culture conditions as in [2] above. Number each colony formed, place a drop of deionized water on the slide glass, disperse the cells collected from the colony using a platinum wire, and sprinkle it with a gas burner from the back. The body was fixed with flame. Crystal violet solution, iodine solution, and safranine solution were sequentially acted on this, and Gram staining was performed. Thereafter, the staining and morphology of the cells contained in each colony were observed with a microscope. At the same time, bacterial species were identified using an apistuff plate and confirmed to be Staphylococcus epidermidis.
[4]表皮ブドウ球菌の純粋培養および乾燥菌体の作製
 表皮ブドウ球菌と同定されたコロニーから採取した菌体を、TS培地上で純粋培養した。得られたコロニーより、白金耳を用いて菌体を採取(1mm径のコロニー1個)し、保護剤としてスキムミルクに分散させ、アンプルへ注入し、-80℃超低温庫で急速凍結させた。これを凍結乾燥機にかけ、乾燥菌体粉末を得た。
[4] Pure culture of Staphylococcus epidermidis and production of dry cells [0104] Cells collected from colonies identified as Staphylococcus epidermidis were purely cultured on TS medium. From the obtained colonies, microbial cells were collected using a platinum loop (one colony having a diameter of 1 mm), dispersed in skim milk as a protective agent, poured into ampoules, and rapidly frozen in a -80 ° C ultra-low temperature chamber. This was subjected to a freeze dryer to obtain dry cell powder.
[5]乾燥菌体の復元
 乾燥菌体を含むアンプルを開封し、液体状のTS培地を少量加え、乾燥菌体を懸濁させた。得られた懸濁液を、液体状のTS培地、平板状のTS培地およびマンニット培地に加え、37℃で48時間培養したところ、いずれの培地からも菌が検出されると共に、平板培地上でコロニーを形成することが確認された。これらの菌体の同定を行ったところ、表皮ブドウ球菌であることが確認された。
[5] Restoration of dried cells Ampoules containing dried cells were opened, and a small amount of liquid TS medium was added to suspend the dried cells. The obtained suspension was added to a liquid TS medium, a plate-like TS medium and a mannitol medium, and cultured at 37 ° C. for 48 hours. Were confirmed to form colonies. When these cells were identified, it was confirmed to be Staphylococcus epidermidis.
実施例2:臨床試験
 20~50代の21名の女性を被験者として、試験の初日に本人の皮膚(額部)から採取した皮膚常在菌より、実施例1に記載の手順を用いて分離および純粋培養した、自己の皮膚常在菌に由来する表皮ブドウ球菌を投与する(戻す)ことが、皮膚表面の表皮ブドウ球菌数および表皮水分量に及ぼす影響を検討した。
Example 2: Clinical study Using 21 females in their 20s to 50s as subjects, separation was performed from the skin resident bacteria collected from the skin (forehead) of the subject on the first day of the test using the procedure described in Example 1. In addition, the effect of administration (returning) of Staphylococcus epidermidis derived from the self-resident resident bacteria on purely cultured skin on the number of staphylococcus epidermidis on the skin surface and the water content of the epidermis was examined.
 21名の被験者を13名の第1群(図1および図2においては「美肌菌戻し群」と表記)と8名の第2群(図1および図2においては「プラセボ群」と表記)とに分け(被験者にはどちらの群に割り当てられたかは知らせなかった。)、基礎化粧品(エタノールフリーの化粧水(ホウリン製)、保湿用ジェル(ホウリン製)および乳液(ホウリン製))を配布した。併せて、第1群には本人の皮膚常在菌由来の表皮ブドウ球菌の乾燥菌体(以下、「乾燥菌体」と略称する。)、第2群にはプラセボ(スキムミルク)をそれぞれ配布した。各群の被験者には、4週間にわたり、化粧水、乾燥菌体(ジェル1回使用量あたり約10億個)またはプラセボを懸濁させた保湿用ジェル、乳液の順で顔の皮膚に塗布することにより、自己の皮膚常在菌由来の表皮ブドウ球菌を投与し(戻し)、またはプラセボを投与する作業(図1において「美肌菌戻し」と表記。以下、総称して「戻し作業」という。)を定期的(各週の1日目と4日目)に実施してもらった。戻し作業の影響を検討するために、額部の皮膚表面の表皮ブドウ球菌数および表皮水分量を定期的(1回/週)に測定した。表皮ブドウ球菌数の測定は、実施例1の[1]、[2]記載の方法により、額部の皮膚表面から採取後培養した皮膚常在菌のコロニーのうち、実施例1の[3]記載の方法により表皮ブドウ球菌のコロニーと同定されたものの数をカウントすることにより行った。後者の測定には、キュートメーターMPA580(皮膚粘弾性測定装置:ドイツ C+K社製)およびコルネオメータープローブを使用した(以上第1クール)。 Twenty-one subjects were classified into a first group of 13 persons (indicated as “rejuvenating skin fungus return group” in FIGS. 1 and 2) and a second group of 8 persons (indicated as “placebo group” in FIGS. 1 and 2). (The subjects were not informed of which group was assigned.) Basic cosmetics (ethanol-free lotion (made by holin), moisturizing gel (made by holin), and milky lotion (made by holin)) were distributed. did. In addition, a dry cell of Staphylococcus epidermidis derived from the skin's own resident bacteria (hereinafter abbreviated as “dry cell”) was distributed to the first group, and a placebo (skimmed milk) was distributed to the second group. . For each group of subjects, apply lotion, dry cells (about 1 billion per gel use) or moisturizing gel with placebo suspended on face skin over 4 weeks, followed by emulsion. Therefore, the operation of administering (returning) Staphylococcus epidermidis derived from the self-resident skin bacterium or the placebo (referred to as “reverting beautiful skin bacteria” in FIG. 1; hereinafter, collectively referred to as “returning operation”). ) On a regular basis (1st and 4th day of each week). In order to examine the effect of the return operation, the number of Staphylococcus epidermidis on the skin surface of the forehead and the water content of the epidermis were measured periodically (once / week). The number of Staphylococcus epidermidis was measured by the method described in [1] and [2] of Example 1, and among the colonies of skin resident bacteria cultured after harvesting from the skin surface of the forehead, [3] of Example 1 This was done by counting the number of those identified as Staphylococcus epidermidis colonies by the method described. For the latter measurement, a cutometer MPA580 (skin viscoelasticity measuring device: manufactured by C + K, Germany) and a Corneometer probe were used (first course).
 第1クール終了後の4週間にわたり、第2群の被験者のみを対象に、プラセボの代わりに乾燥菌体を配布した以外は第1クールと同様の条件で、自己の皮膚常在菌由来の表皮ブドウ球菌の戻し作業をしてもらった。戻し作業の影響を検討するために、額部の皮膚表面の表皮ブドウ球菌数を定期的(2週間おき)に測定した。第1群の被験者については、第1クール終了後4週間経過時に、額部の皮膚表面の表皮ブドウ球菌数を測定した(以上第2クール)。 For 4 weeks after the end of the first course, only the subjects in the second group were subject to the same conditions as in the first course except that dry cells were distributed instead of placebo. We had you return work of staphylococci. In order to examine the effect of the return operation, the number of Staphylococcus epidermidis on the skin surface of the forehead was measured periodically (every two weeks). For the subjects of the first group, the number of Staphylococcus epidermidis on the skin surface of the forehead was measured when 4 weeks passed after the end of the first course (second course).
 図1に、各群における臨床試験開始前の表皮ブドウ球菌数を1とした場合の表皮ブドウ球菌数(「美肌菌相対数」と表記。)の経時変化を示す。第1群において、皮膚表面の表皮ブドウ球菌数は、自己の皮膚常在菌由来の表皮ブドウ球菌を投与する(戻す)ことにより有意に増大しているが、第1クールを終え、戻し作業を止めると減少に転じた。一方、第2群においては、プラセボを投与している間は皮膚表面の表皮ブドウ球菌数がほぼ一定であるのに対し、自己の皮膚常在菌由来の表皮ブドウ球菌の戻し作業に切り替えると有意な増加が見られた。これらの結果は、(1)自己の皮膚常在菌由来の表皮ブドウ球菌を投与する(戻す)ことにより、皮膚表面に表皮ブドウ球菌が確実に定着すること、(2)戻し作業終了後、皮膚表面の表皮ブドウ球菌数が減少することから継続的に投与(戻し作業)を行うことが好ましいことを示唆している。 FIG. 1 shows the change over time in the number of Staphylococcus epidermidis (expressed as “relative number of skin-skins”) when the number of Staphylococcus epidermidis before the start of clinical trials in each group is 1. In the first group, the number of Staphylococcus epidermidis on the skin surface is significantly increased by administering (returning) Staphylococcus epidermidis derived from its own skin resident bacteria. When it stopped, it turned to decrease. On the other hand, in the second group, the number of Staphylococcus epidermidis on the skin surface is almost constant while the placebo is administered, whereas it is significant when switching to the returning operation of Staphylococcus epidermidis derived from its own skin resident bacteria. Increase was seen. These results are as follows: (1) staphylococcus epidermidis derived from its own skin resident bacteria is administered (returned), and staphylococcus epidermidis reliably settles on the skin surface. (2) Since the number of Staphylococcus epidermidis on the surface decreases, it is suggested that continuous administration (returning operation) is preferable.
 図2に、第1群および第2群における、第1クール終了前後の額部の表皮水分量(肌水分相対値)を示す。第1群において、第1クールにおける3~4週間の自己の皮膚常在菌由来の表皮ブドウ球菌を投与する(戻す)ことにより表皮水分量が有意に増大していることが確認された。一方第2群においては、第1クールを通して表皮水分量はほぼ一定であることが観測された。 FIG. 2 shows the amount of skin moisture (relative value of skin moisture) in the forehead before and after the end of the first cool in the first group and the second group. In the first group, it was confirmed that the amount of water in the epidermis was significantly increased by administering (returning) Staphylococcus epidermidis derived from the resident bacteria of the skin for 3 to 4 weeks in the first course. On the other hand, in the second group, it was observed that the water content of the epidermis was almost constant throughout the first course.
 これらの結果は、自己の皮膚常在菌由来の表皮ブドウ球菌を自己の皮膚に投与する(戻す)ことにより、皮膚常在菌叢において表皮ブドウ球菌が優勢となり、それに伴って皮膚の健康状態の一指標である表皮水分量が改善されたことを強く示唆している。 These results show that staphylococcus epidermidis derived from its own skin resident bacteria is administered (returned) to its own skin, so that staphylococcus epidermidis predominates in the resident skin flora, and accordingly, the health condition of the skin It strongly suggests that the moisture content of the epidermis, which is one index, has been improved.

Claims (18)

  1.  ヒトの皮膚表面に生息する細菌を採取する工程と、
     前記細菌のうち、ヒトの皮膚表面で増殖し、皮膚の健康状態を改善させる1または複数種の有用菌を選択的に増殖させる工程と、
     前記増殖させた有用菌の菌体、菌体成分および前記有用菌の産生物質からなる群より選択される1または複数を含む組成物をヒトの皮膚に投与する工程とを有することを特徴とする美容方法。
    Collecting bacteria that inhabit the human skin surface;
    A step of selectively growing one or more useful bacteria that grow on the surface of human skin and improve skin health among the bacteria,
    Administering to the human skin a composition containing one or more selected from the group consisting of the cells of the useful bacteria grown, the bacterial cell components, and the substances produced by the useful bacteria Beauty method.
  2.  前記投与する工程において、前記細菌を採取したのと同一のヒト個体に前記組成物の投与(戻し)を行うことを特徴とする請求項1記載の美容方法。 The cosmetic method according to claim 1, wherein in the administering step, the composition is administered (returned) to the same human individual from whom the bacteria were collected.
  3.  前記細菌が皮膚常在菌であることを特徴とする請求項1または2記載の美容方法。 The cosmetic method according to claim 1 or 2, wherein the bacteria are skin resident bacteria.
  4.  前記1または複数種の有用菌を選択的に増殖させる工程が、
     採取した前記細菌を培地上で培養する予備培養工程と、
     前記培養した細菌から前記有用菌を選抜する選抜工程と、
     前記選抜した有用菌を培養する培養工程とを含むことを特徴とする請求項1から3のいずれか1項記載の美容方法。
    The step of selectively growing the one or more kinds of useful bacteria,
    A pre-culturing step of culturing the collected bacteria on a medium;
    A selection step of selecting the useful bacteria from the cultured bacteria;
    The cosmetic method according to any one of claims 1 to 3, further comprising a culture step of culturing the selected useful bacteria.
  5.  前記細菌がヒトの健全な状態の皮膚表面に生息するものであることを特徴とする請求項1から4のいずれか1項記載の美容方法。 The cosmetic method according to any one of claims 1 to 4, wherein the bacteria live on the skin surface of a healthy human being.
  6.  前記有用菌がコアグラーゼ陰性ブドウ球菌であることを特徴とする請求項1から5のいずれか1項記載の美容方法。 The cosmetic method according to any one of claims 1 to 5, wherein the useful bacteria are coagulase-negative staphylococci.
  7.  前記有用菌が表皮ブドウ球菌(Staphylococcus epidermidis)であることを特徴とする請求項6記載の美容方法。 The cosmetic method according to claim 6, wherein the useful bacterium is Staphylococcus epidermidis.
  8.  ヒトの皮膚表面から採取した細菌より分離し選択的に増殖させた、ヒトの皮膚表面で増殖し、皮膚の健康状態を改善させる1または複数種の有用菌の菌体、菌体成分および前記有用菌の産生物質からなる群より選択される1または複数を含むことを特徴とするスキンケア用組成物。 One or a plurality of useful bacterial cells, bacterial components, and the above-mentioned useful substances that have been isolated and selectively grown from bacteria collected from the human skin surface, and that grow on the human skin surface and improve the health of the skin A composition for skin care, comprising one or more selected from the group consisting of fungal product.
  9.  前記細菌が皮膚常在菌であることを特徴とする請求項8記載のスキンケア用組成物。 The skin care composition according to claim 8, wherein the bacteria are skin resident bacteria.
  10.  前記細菌がヒトの健全な状態の皮膚表面に生息するものであることを特徴とする請求項8または9記載のスキンケア用組成物。 10. The skin care composition according to claim 8 or 9, wherein the bacteria live on the skin surface of a healthy human state.
  11.  前記有用菌がコアグラーゼ陰性ブドウ球菌であることを特徴とする請求項8から10のいずれか1項記載のスキンケア用組成物。 The skin care composition according to any one of claims 8 to 10, wherein the useful bacteria are coagulase-negative staphylococci.
  12.  前記有用菌が表皮ブドウ球菌(Staphylococcus epidermidis)であることを特徴とする請求項11記載のスキンケア用組成物。 12. The skin care composition according to claim 11, wherein the useful bacterium is Staphylococcus epidermidis.
  13.  ヒトの皮膚表面から採取した細菌のうち、ヒトの皮膚表面で増殖し、皮膚の健康状態を改善させる1または複数種の有用菌を選択的に増殖させて得られる菌体。 A bacterial cell obtained by selectively proliferating one or more useful bacteria that grow on the human skin surface and improve the health of the skin among the bacteria collected from the human skin surface.
  14.  前記細菌が皮膚常在菌であることを特徴とする請求項13記載の菌体。 The bacterium according to claim 13, wherein the bacterium is a resident skin bacterium.
  15.  前記細菌が、ヒトの健全な状態の皮膚表面に生息するものであることを特徴とする請求項13または14記載の菌体。 15. The microbial cell according to claim 13 or 14, wherein the bacterium lives on the skin surface of a healthy human state.
  16.  前記有用菌がコアグラーゼ陰性ブドウ球菌であることを特徴とする請求項13から15のいずれか1項記載の菌体。 The microbial cell according to any one of claims 13 to 15, wherein the useful bacterium is a coagulase-negative staphylococci.
  17.  前記有用菌が表皮ブドウ球菌(Staphylococcus epidermidis)であることを特徴とする請求項16記載の菌体。 The microbial cell according to claim 16, wherein the useful bacterium is Staphylococcus epidermidis.
  18.  請求項13から17のいずれか1項記載の菌体を乾燥させて得られる乾燥菌体。 A dried microbial cell obtained by drying the microbial cell according to any one of claims 13 to 17.
PCT/JP2012/078835 2011-11-18 2012-11-07 Beauty treatment method, skin care composition, bacterial cell, and dried bacterial cell WO2013073431A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201280056675.7A CN103945829B (en) 2011-11-18 2012-11-07 Beauty method, protect skin composition, thalline and dry thalline
JP2013541091A JP5584833B2 (en) 2011-11-18 2012-11-07 Beauty method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011-253056 2011-11-18
JP2011253056 2011-11-18

Publications (1)

Publication Number Publication Date
WO2013073431A1 true WO2013073431A1 (en) 2013-05-23

Family

ID=48429494

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2012/078835 WO2013073431A1 (en) 2011-11-18 2012-11-07 Beauty treatment method, skin care composition, bacterial cell, and dried bacterial cell

Country Status (4)

Country Link
JP (2) JP5584833B2 (en)
KR (1) KR101406808B1 (en)
CN (1) CN103945829B (en)
WO (1) WO2013073431A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
US10874700B2 (en) 2016-03-31 2020-12-29 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
CN112442456A (en) * 2019-08-27 2021-03-05 科丝美诗株式会社 Staphylococcus strains and uses thereof
CN114058559A (en) * 2022-01-17 2022-02-18 山东锦鲤生物工程有限公司 Staphylococcus epidermidis and application thereof
US11564879B2 (en) 2016-11-23 2023-01-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102587334B1 (en) * 2015-06-30 2023-10-12 (주)아모레퍼시픽 Strains for improving skin, and kit for improving skin using the same
WO2018216744A1 (en) * 2017-05-23 2018-11-29 一丸ファルコス株式会社 Cosmetic and skin protecting agent containing lactic acid bacterium
JP7219033B2 (en) * 2018-09-14 2023-02-07 ポーラ化成工業株式会社 M. Skin external composition containing aerilata as an active ingredient
CN113413327B (en) * 2021-06-21 2022-04-29 山东焦点福瑞达生物股份有限公司 Preparation method of polysaccharide skin microecological cosmetic

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06135843A (en) * 1992-10-23 1994-05-17 Sagami Chem Res Center Agent for skin
JPH06271851A (en) * 1993-03-19 1994-09-27 Narisu Keshohin:Kk Antioxidant and cosmetic
JPH0977653A (en) * 1995-09-14 1997-03-25 Advance Co Ltd Cosmetic
JPH09157128A (en) * 1995-12-05 1997-06-17 Advance Co Ltd Cosmetic material
JP2000128783A (en) * 1998-10-23 2000-05-09 Lion Corp Gram-negative bacterium-resistant agent
JP2005304363A (en) * 2004-04-20 2005-11-04 Hakuto Co Ltd Anti-oxidizing substance secretion-promoting agent and method for producing anti-oxidizing substance
JP2006219414A (en) * 2005-02-10 2006-08-24 Showa Denko Kk External preparation for skin, method for preventing adhesion of microorganism harmful to skin by using the same and method for preventing proliferation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0637384B2 (en) * 1985-09-21 1994-05-18 株式会社資生堂 Skin cosmetics
JP2003321341A (en) * 2002-05-07 2003-11-11 Sankodo:Kk Dermatologic medicine

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06135843A (en) * 1992-10-23 1994-05-17 Sagami Chem Res Center Agent for skin
JPH06271851A (en) * 1993-03-19 1994-09-27 Narisu Keshohin:Kk Antioxidant and cosmetic
JPH0977653A (en) * 1995-09-14 1997-03-25 Advance Co Ltd Cosmetic
JPH09157128A (en) * 1995-12-05 1997-06-17 Advance Co Ltd Cosmetic material
JP2000128783A (en) * 1998-10-23 2000-05-09 Lion Corp Gram-negative bacterium-resistant agent
JP2005304363A (en) * 2004-04-20 2005-11-04 Hakuto Co Ltd Anti-oxidizing substance secretion-promoting agent and method for producing anti-oxidizing substance
JP2006219414A (en) * 2005-02-10 2006-08-24 Showa Denko Kk External preparation for skin, method for preventing adhesion of microorganism harmful to skin by using the same and method for preventing proliferation

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
US10874700B2 (en) 2016-03-31 2020-12-29 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US11633451B2 (en) 2016-03-31 2023-04-25 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
US11564879B2 (en) 2016-11-23 2023-01-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
CN112442456A (en) * 2019-08-27 2021-03-05 科丝美诗株式会社 Staphylococcus strains and uses thereof
CN114058559A (en) * 2022-01-17 2022-02-18 山东锦鲤生物工程有限公司 Staphylococcus epidermidis and application thereof

Also Published As

Publication number Publication date
CN103945829A (en) 2014-07-23
CN103945829B (en) 2016-08-24
JP5584833B2 (en) 2014-09-03
JP6023756B2 (en) 2016-11-09
JPWO2013073431A1 (en) 2015-04-02
JP2014177489A (en) 2014-09-25
KR20130055495A (en) 2013-05-28
KR101406808B1 (en) 2014-06-12

Similar Documents

Publication Publication Date Title
JP6023756B2 (en) Composition for skin care, fungus body, dried fungus body and collection tool
US9050288B2 (en) Cleanser compositions and methods for using the same
JP6752771B2 (en) Topical composition and usage
US20040009138A1 (en) Skin cleanser compositions and methods of use
CN113908074A (en) Nicotinamide for inducing antimicrobial peptide production
CN109260059B (en) Essential oil composition with acne removing and skin repairing effects and application thereof
CN103813799A (en) Disinfecting formulations and uses thereof
WO2017042748A1 (en) Moisturizing cosmetic composition
CN103249419B (en) There is antibacterial and wound healing activity compositions
CN105899221A (en) Dermatological composition based on algae and olive leaf extracts
Hahn et al. Analysis of epidermal entry in experimental cutaneous Bacillus anthracis infections in mice
KR102380211B1 (en) Cosmetic composition having antibacterial effect including immune cell conditioned media
JP2021155370A (en) Cosmetic, cosmetic composition, and method for producing cosmetic composition
US20220193025A1 (en) Use of dianhydrohexitol to eliminate the cosmetic effects of acne, dandruff and bad odors
Griggs The Comparison of Bacteria Populations under Artificial and Natural Nails, and the Effect of Hand Cleansing with Alcohol Based Gels and Antibacterial Soap
KR20110058260A (en) Cosmetic composition
CN110536676A (en) The new compositions and preparation method thereof that can be obtained by Extra Virgin
ITMI20111807A1 (en) SANITIZING COMPOSITION FOR EXTERNAL TOPIC USE
NZ620616B2 (en) Disinfecting formulations and uses thereof
BRPI1005866A2 (en) the use of phiyllanthus, its extract or any of its derivatives as an antimicrobial agent and for its bactericidal, fungicidal, antiseptic, varicidal and acaricidal characteristics

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12849039

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2013541091

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12849039

Country of ref document: EP

Kind code of ref document: A1